Dosimetric Evaluation of Two Multileaf Collimator Systems in Simultaneous Integrated Boost Volumetric Modulated Arc Therapy for Stage IIIC Cervical Cancer with Lymph Node Metastases - Report - MDSpire
Advertisement
Dosimetric Evaluation of Two Multileaf Collimator Systems in Simultaneous Integrated Boost Volumetric Modulated Arc Therapy for Stage IIIC Cervical Cancer with Lymph Node Metastases
Clinical Report: Dosimetric Evaluation of MLC Systems in SIB-VMAT for Cervical Cancer
Overview
Expand on the implications of superior organ-at-risk sparing in clinical practice.
Background
Lymph node metastasis is a significant prognostic factor in cervical cancer, influencing treatment outcomes and survival rates. Effective regional nodal control is essential, especially in advanced stages like FIGO stage IIIC. Radiotherapy, particularly SIB-VMAT, plays a crucial role in managing these patients while minimizing toxicity to surrounding organs.
Data Highlights
MLC System
Target Coverage
OAR Dose Reduction
α-MLC
Clinically acceptable
Significant reduction in doses to small intestine, colon, rectum, bladder, femoral heads, cauda equina, and spinal cord
p-MLC
Clinically acceptable
Less effective in OAR sparing
Key Findings
Both MLC systems achieved clinically acceptable target coverage across all lymph node metastasis subgroups.
The α-MLC system showed improved dose gradient control for the planning target volume (PTV) in bilateral pelvic lymph node metastases.
Dosimetric parameters for PTV and PGTVnd were comparable between both systems.
Significant differences in organ-at-risk sparing were noted, with α-MLC consistently reducing doses across multiple organs.
Statistical significance was observed (p < 0.05) for OAR sparing with the α-MLC system.
Clinical Implications
The findings suggest that the α-MLC system may be preferred in clinical practice for SIB-VMAT in patients with complex lymph node metastases due to its superior OAR sparing. This could lead to reduced treatment-related toxicities and improved patient quality of life.
Conclusion
Both multileaf collimator systems are effective for target coverage in advanced cervical cancer, but the α-MLC system offers significant advantages in sparing surrounding organs. These insights can guide equipment selection and treatment planning strategies.
